I

Instituto San Marcos | San Juan, Argentina

Research site
(Unclaimed)
Location
Calle D. F. Sarmiento 92 norte, San Juan, San Juan, Argentina

Site insights

Top conditions

Top treatments

Pembrolizumab
Anastrozole
Letrozole
Imlunestrant
Tamoxifen
MK-3475-859
Exemestane
Abemaciclib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 5 total trials

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer (EMBER-4)

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...

Enrolling
Breast Neoplasms
Drug: Anastrozole
Drug: Tamoxifen

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy, and how well imlunestrant with abemaci...

Enrolling
Neoplasm Metastasis
Breast Neoplasms
Drug: Exemestane
Drug: Imlunestrant

The purpose of this study is to evaluate participant preference for coformulated hyaluronidase/pembrolizumab (MK-3475A) administered subcutaneously (...

Enrolling
Melanoma
Renal Cell Carcinoma
Biological: Pembrolizumab
Biological: Pembrolizumab co-formulated with hyaluronidase

The purpose of this study is to assess the efficacy and safety of pembrolizumab plus lenvatinib plus chemotherapy compared with pembrolizumab plus ch...

Enrolling
Metastatic Esophageal Squamous Cell Carcinoma
Drug: Paclitaxel
Drug: Lenvatinib

The purpose of this study is to evaluate the efficacy of pembrolizumab (MK-3745) in combination with chemotherapy (Cisplatin combined with 5-Fluorour...

Active, not recruiting
Stomach Neoplasms
Drug: capecitabine
Drug: Cisplatin

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems